Poor quality of life and incomplete self-reported adherence predict second-line ART virological failure in resource-limited settings

References

• Anastos, K., Schneider, M. F., Gange, S. J., Minkoff, H., Greenblatt, R. M., Feldman, J., Levine, A., Delapenha, R., & Cohen, M. (2005). The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. Journal of Acquired Immune Deficiency Syndromes, 39(5), 537–544. https://doi.org/10.1097/01.qai.0000172370.90079.3b
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423. https://doi.org/10.1086/323201
   PubMed Web of Science ®Google Scholar
• Barfod, T. S., Gerstoft, J., Rodkjaer, L., Pedersen, C., Nielsen, H., Møller, A., Kristensen, L. H., Sørensen, H. T., & Obel, N. (2005). Patients’ answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: A cross-sectional survey. AIDS Patient Care and STDs, 19(5), 317–325. https://doi.org/10.1089/apc.2005.19.317
   PubMed Web of Science ®Google Scholar
• Bavinton, B. R., Pinto, A. N., Phanuphak, N., Grinsztejn, B., Prestage, G. P., Zablotska-Manos, I. B., Jin, F., Fairley, C. K., Moore, R., Roth, N., Bloch, M., Pell, C., McNulty, A. M., Baker, D., Hoy, J., Tee, B. K., Templeton, D. J., Cooper, D. A., Emery, S., … Pinto, A. N. (2018). Viral suppression and HIV transmission in serodiscordant male couples: An international, prospective, observational, cohort study. The Lancet HIV, 5(8), e438–e447. https://doi.org/10.1016/S2352-3018(18)30132-2
   PubMed Web of Science ®Google Scholar
• Bhatta, D. N., & Liabsuetrakul, T. (2017). Efficacy of a social self-value empowerment intervention to improve quality of life of HIV infected people receiving antiretroviral treatment in Nepal: A randomized controlled trial. AIDS and Behavior, 21(6), 1620–1631. https://doi.org/10.1007/s10461-016-1546-z
   PubMed Web of Science ®Google Scholar
• Boyd, M. A., Moore, C. L., Molina, J.-M., Wood, R., Madero, J. S., Wolff, M., Ruxrungtham, K., Losso, M., Renjifo, B., Teppler, H., Kelleher, A. D., Amin, J., Emery, S., & Cooper, D. A. (2015). Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis. The Lancet HIV, 2(2), e42–e51. https://doi.org/10.1016/S2352-3018(14)00061-7
   PubMed Web of Science ®Google Scholar
• Breitbart, W., Passik, S., McDonald, M. V., Rosenfeld, B., Smith, M., Kaim, M., & Funesti-Esch, J. (1998). Patient-related barriers to pain management in ambulatory AIDS patients. Pain, 76(1), 9–16. https://doi.org/10.1016/S0304-3959(98)00018-9
   PubMed Web of Science ®Google Scholar
• Bucciardini, R., D’ettorre, G., Baroncelli, S., Ceccarelli, G., Parruti, G., Weimer, L. E., Fragola, V., Galluzzo, C. M., Pirillo, M. F., Lucattini, S., Bellagamba, R., Francisci, D., Ladisa, N., Antoni, A. D., Guaraldi, G., Manconi, P. E., Vullo, V., Preziosi, R., Cirioni, O., … Floridia, M. (2012). Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors. International Journal of STD & AIDS, 23(7), 459–463. https://doi.org/10.1258/ijsa.2012.011391
   PubMed Web of Science ®Google Scholar
• Canan, C., Alexander, G. C., Moore, R., Murimi, I., Chander, G., & Lau, B. (2019). Medicaid trends in prescription opioid and non-opioid use by HIV status. Drug and Alcohol Dependence, 197, 141–148. https://doi.org/10.1016/j.drugalcdep.2018.11.034
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. https://doi.org/10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Costa, J. d. M., Torres, T. S., Coelho, L. E., & Luz, P. M. (2018). Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis. Journal of the International AIDS Society, 21(1), e25066. https://doi.org/10.1002/jia2.25066
   PubMedGoogle Scholar
• Denis, C. M., Morales, K. H., Wu, Q., Metzger, D. S., & Cheatle, M. D. (2019). Association between diagnoses of chronic noncancer pain, substance use disorder, and HIV-related outcomes in people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes, 82, S142–S147. https://doi.org/10.1097/QAI.0000000000002179
   PubMed Web of Science ®Google Scholar
• Etoori, D., Ciglenecki, I., Ndlangamandla, M., Edwards, C. G., Jobanputra, K., Pasipamire, M., Maphalala, G., Yang, C., Zabsonre, I., Kabore, S. M., Goiri, J., Teck, R., & Kerschberger, B. (2018). Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland. Journal of the International AIDS Society, 21(10), e25194. https://doi.org/10.1002/jia2.25194
   PubMed Web of Science ®Google Scholar
• Garofalo, R., Kuhns, L. M., Hotton, A., Johnson, A., Muldoon, A., & Rice, D. (2016). A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS and Behavior, 20(5), 1049–1059. https://doi.org/10.1007/s10461-015-1192-x
   PubMed Web of Science ®Google Scholar
• Geocze, L., Mucci, S., De Marco, M. A., Nogueira-Martins, L. A., & Citero, V. d. A. (2010). Qualidade de vida e adesão ao tratamento anti-retroviral de pacientes portadores de HIV. Revista de Saúde Pública, 44(4), 743–749. https://doi.org/10.1590/S0034-89102010000400019
   PubMed Web of Science ®Google Scholar
• Gorman, A. A., Foley, J. M., Ettenhofer, M. L., Hinkin, C. H., & van Gorp, W. G. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2), 186–203. https://doi.org/10.1007/s11065-009-9095-0
   PubMed Web of Science ®Google Scholar
• Gross, R., Ritz, J., Hughes, M. D., Salata, R., Mugyenyi, P., Hogg, E., Wieclaw, L., Godfrey, C., Wallis, C. L., Mellors, J. W., Mudhune, V. O., Badal-Faesen, S., Grinsztejn, B., & Collier, A. C. (2019). Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: A multinational, randomised controlled trial. The Lancet Digital Health, 1(1), e26–e34. https://doi.org/10.1016/S2589-7500(19)30006-8
   PubMedGoogle Scholar
• Hari Chandra, B., Ramesh, M., & Nagendra, H. (2019). Effect of yoga on immune parameters, cognitive functions, and quality of life among HIV-positive children/adolescents: A pilot study. International Journal of Yoga, 12(2), 132. https://doi.org/10.4103/ijoy.IJOY_51_18
   PubMedGoogle Scholar
• Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., Thrasher, D., Goetz, M. B., & Stefaniak, M. (2002). Medication Adherence among HIV + Adults, 59, 12. https://doi.org/10.1212/01.WNL.0000038347.48137.67
   Google Scholar
• The INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373(9), 795–807. https://doi.org/10.1056/NEJMoa1506816
   PubMed Web of Science ®Google Scholar
• Isenberg, S. R., Maragh-Bass, A. C., Ridgeway, K., Beach, M. C., & Knowlton, A. R. (2017). A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders. Journal of Opioid Management, 13(1), 5. https://doi.org/10.5055/jom.2017.0363
   PubMedGoogle Scholar
• Krashin, D. L., Merrill, J. O., & Trescot, A. M. (2012). Opioids in the management of HIV-related pain. Pain Physician, 15(3 Suppl), ES157–68.
   PubMed Web of Science ®Google Scholar
• La Rosa, A. M., Harrison, L. J., Taiwo, B., Wallis, C. L., Zheng, L., Kim, P., Kumarasamy, N., Hosseinipour, M. C., Jarocki, B., Mellors, J. W., & Collier, A. C. (2016). Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): A randomised, phase 3, non-inferiority study. The Lancet HIV, 3(6), e247–e258. https://doi.org/10.1016/S2352-3018(16)30011-X
   PubMed Web of Science ®Google Scholar
• Miaskowski, C., Penko, J. M., Guzman, D., Mattson, J. E., Bangsberg, D. R., & Kushel, M. B. (2011). Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. The Journal of Pain, 12(9), 1004–1016. https://doi.org/10.1016/j.jpain.2011.04.002
   PubMed Web of Science ®Google Scholar
• Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodríguez, E., Warren, M. R., & Vejo, J. (2011). Adherence to highly active antiretroviral therapy (HAART): A meta-analysis. AIDS and Behavior, 15(7), 1381–1396. https://doi.org/10.1007/s10461-011-9942-x
   PubMed Web of Science ®Google Scholar
• Parker, R. A., Rabideau, D. J., Sax, P. E., Tierney, C., Daar, E. S., Collier, A. C., Losina, E., & Freedberg, K. A. (2017). Impact of medication adherence on virologic failure in A5202: A randomized, partially blinded, phase 3B study. Clinical Infectious Diseases, 64(11), 1612–1614. https://doi.org/10.1093/cid/cix176
   PubMed Web of Science ®Google Scholar
• Parker, R., Stein, D. J., & Jelsma, J. (2014). Pain in people living with HIV/AIDS: A systematic review. Journal of the International AIDS Society, 17(1), 18719. https://doi.org/10.7448/IAS.17.1.18719
   PubMedGoogle Scholar
• Remien, R. H., Stirratt, M. J., Nguyen, N., Robbins, R. N., Pala, A. N., & Mellins, C. A. (2019). Mental health and HIV/AIDS: The need for an integrated response. Aids (London, England), 33(9), 1411–1420. https://doi.org/10.1097/QAD.0000000000002227
   PubMed Web of Science ®Google Scholar
• Rendina, H. J., & Parsons, J. T. (2018). Factors associated with perceived accuracy of the Undetectable = Untransmittable slogan among men who have sex with men: Implications for messaging scale-up and implementation. Journal of the International AIDS Society, 21(1), e25055. https://doi.org/10.1002/jia2.25055
   PubMed Web of Science ®Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Raben, D., Coll, P., Antinori, A., Nwokolo, N., Rieger, A., Prins, J. M., Blaxhult, A., Weber, R., Van Eeden, A., … Janeiro, N. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. The Lancet, 393(10189), 2428–2438. https://doi.org/10.1016/S0140-6736(19)30418-0
   PubMed Web of Science ®Google Scholar
• Safren, S. A., Biello, K. B., Smeaton, L., Mimiaga, M. J., Walawander, A., Lama, J. R., Rana, A., Nyirenda, M., Kayoyo, V. M., Samaneka, W., Joglekar, A., Celentano, D., Martinez, A., Remmert, J. E., Nair, A., Lalloo, U. G., Kumarasamy, N., Hakim, J., Campbell, T. B., Thorne, C., & for the PEARLS (ACTG A5175) Study Team. (2014). Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: Data from the ACTG A5175/PEARLS trial. PLoS One, 9(8), e104178. https://doi.org/10.1371/journal.pone.0104178
   PubMed Web of Science ®Google Scholar
• Safren, S. A., Hendriksen, E. S., Smeaton, L., Celentano, D. D., Hosseinipour, M. C., Barnett, R., Guanira, J., Flanigan, T., Kumarasamy, N., Klingman, K., & Campbell, T. (2012). Quality of life Among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS and Behavior, 16(2), 266–277. https://doi.org/10.1007/s10461-011-9947-5
   PubMed Web of Science ®Google Scholar
• Schackman, B. R., Ribaudo, H. J., Krambrink, A., Hughes, V., Kuritzkes, D. R., & Gulick, R. M. (2007). Racial differences in virologic failure associated with adherence and quality of life on Efavirenz-containing regimens for initial HIV therapy: Results of ACTG A5095. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(5), 547–554. https://doi.org/10.1097/QAI.0b013e31815ac499
   PubMed Web of Science ®Google Scholar
• Shahani, L., Salazar, L., Woods, S. P., & Hasbun, R. (2018). Baseline neurocognitive functioning predicts viral load suppression at 1-year follow-up among newly diagnosed HIV infected patients. AIDS and Behavior, 22(10), 3209–3213. https://doi.org/10.1007/s10461-018-2025-5
   PubMed Web of Science ®Google Scholar
• Smith, K., Powers, K. A., Kashuba, A. D., & Cohen, M. S. (2011). HIV-1 treatment as prevention: The good, the bad, and the challenges. Current Opinion in HIV and AIDS, 1. https://doi.org/10.1097/COH.0b013e32834788e7
   PubMed Web of Science ®Google Scholar
• Surratt, H. L., Kurtz, S. P., Levi-Minzi, M. A., Cicero, T. J., Tsuyuki, K., & O’Grady, C. L. (2015). Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive patients. AIDS Patient Care and STDs, 29(4), 186–192. https://doi.org/10.1089/apc.2014.0104
   PubMed Web of Science ®Google Scholar
• Torres, T. S., Cox, J., Marins, L. M., Bezerra, D. R., Veloso, V. G., Grinsztejn, B., & Luz, P. M. (2020). A call to improve understanding of undetectable equals untransmittable (U = U) in Brazil: A web-based survey. Journal of the International AIDS Society, 23(11), e25630. https://doi.org/10.1002/jia2.25630
   PubMed Web of Science ®Google Scholar
• Torres, T. S., Harrison, L. J., La Rosa, A. M., Cardoso, S. W., Zheng, L., Ngongondo, M., Some, F., Lalloo, U. G., Mwelase, T., Collier, A. C., & Hughes, M. D. (2018). Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS (London, England), 32(5), 583–593. https://doi.org/10.1097/QAD.0000000000001738
   PubMed Web of Science ®Google Scholar
• Torres, T. S., Harrison, L. J., La Rosa, A. M., Lavenberg, J. A., Zheng, L., Safren, S. A., Ngongondo, M., Poongulali, S., Matoga, M., Samaneka, W., Collier, A. C., & Hughes, M. D. (2018). Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings. AIDS Care, 30(8), 954–962. https://doi.org/10.1080/09540121.2018.1427207
   PubMed Web of Science ®Google Scholar
• Uebelacker, L. A., Weisberg, R. B., Herman, D. S., Bailey, G. L., Pinkston-Camp, M. M., & Stein, M. D. (2015). Chronic pain in HIV-infected patients: Relationship to depression, substance use, and mental health and pain treatment. Pain Medicine, 16(10), 1870–1881. https://doi.org/10.1111/pme.12799
   PubMed Web of Science ®Google Scholar
• WHO. (2015). Global forecasts of antiretroviral demand for 2014–2018, projection modelling for new antiretroviral formulations for 2015–2024 and update on hepatitis B & C. https://www.who.int/hiv/amds/ARV-forecasting-meeting-2015/en/
   Google Scholar
• WHO. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. http://www.ncbi.nlm.nih.gov/books/NBK374294/
   Google Scholar
• Wilson, I. B. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA, 273(1), 59. https://doi.org/10.1001/jama.1995.03520250075037
   PubMed Web of Science ®Google Scholar